Sphingomonas paucimobilis: PCR Detection and Clinical Overview
Sphingomonas paucimobilis is a Gram-negative, strictly aerobic, non-fermentative bacillus widely distributed in soil, water, and hospital environments. It is an opportunistic pathogen primarily associated with nosocomial infections, particularly bacteremia and respiratory infections. Its name reflects two key features: production of sphingolipids and limited motility.
Sphingomonas paucimobilis is a Gram-negative, strictly aerobic, non-fermentative bacillus widely distributed in soil, water, and hospital environments. It is an opportunistic pathogen primarily associated with nosocomial infections, particularly bacteremia and respiratory infections. Its name reflects two key features: production of sphingolipids and limited motility.
I
Biological Characteristics
S. paucimobilis is a slender Gram-negative rod with a single polar flagellum and weak motility.
It is oxidase-positive and catalase-positive, and does not form spores.
A unique feature is its cell wall composition: sphingoglycolipids replace lipopolysaccharide (LPS), resulting in lower endotoxin activity.
The organism demonstrates remarkable environmental resilience, surviving over 30 days in low-nutrient conditions such as distilled water.
It can degrade aromatic hydrocarbons, making it useful in bioremediation applications.
II
Culture Characteristics
Culture is performed on blood agar or chocolate agar under aerobic conditions at 35°C for 24–48 hours.
Colonies are typically 1–2 mm in diameter, smooth, moist, and range from pale yellow to bright yellow due to pigment production.
After 72 hours, colonies may develop deeper orange pigmentation.
III
Clinical Infections
Common infections include catheter-related bacteremia, respiratory infections (often ventilator-associated pneumonia), and less frequently peritonitis or postoperative endophthalmitis.
Infections typically progress slowly compared to pathogens such as Pseudomonas aeruginosa.
Symptoms of bacteremia include fever and chills, often without a clear infection focus.
IV
Laboratory Diagnosis
Culture identification: Growth of yellow colonies on blood agar, with biochemical profiles showing glucose oxidation positive, maltose oxidation positive, and lactose negative.
Molecular methods: Identification using 16S rRNA gene sequencing and gyrB gene analysis.
V
Inactivation and Disinfection
Effective sterilization includes moist heat (121°C for 15 minutes) and dry heat (160°C for 1 hour).
Chemical disinfection methods include chlorine-based disinfectants (500 ppm for 10 minutes), 70% ethanol (1 minute), and 0.5% peracetic acid (30 minutes).
Biofilm formation significantly increases resistance to disinfection, requiring combined mechanical cleaning and enzymatic detergents.
VI
Antimicrobial Therapy
First-line treatments include fluoroquinolones such as ciprofloxacin and levofloxacin, as well as trimethoprim-sulfamethoxazole.
For severe or resistant infections, carbapenems (e.g., meropenem) or third-generation cephalosporins (e.g., cefotaxime) may be used.
The organism exhibits intrinsic resistance to ampicillin, first-generation cephalosporins (due to AmpC β-lactamase), and aminoglycosides, with gentamicin resistance exceeding 80%.
VII
Biological Significance
S. paucimobilis is notable for its dual role as both an environmental bacterium and an opportunistic pathogen.
Its low endotoxin activity and environmental adaptability distinguish it from other Gram-negative pathogens.
Understanding its resistance mechanisms and biofilm formation is essential for effective infection control.
PCR KIT
Related Product
Sphingomonas paucimobilis Probe Realtime PCR Kit
Catalog No.: BF-95148250
This real-time PCR kit enables rapid, sensitive, and specific detection of Sphingomonas paucimobilis, supporting clinical research and environmental monitoring.
BIOFARGO TEAM
